CRYMCryomass Technologies Inc.

About Cryomass Technologies Inc. (CRYM)

Cryomass Technologies Inc. (CRYM) is a Drug Manufacturers - Specialty & Generic company headquartered in Denver, CO, United States whose shares trade over-the-counter on the OTCQB tier.

CryoMass Technologies Inc develops and licenses cutting-edge equipment and processes to refine harvested cannabis, hemp, and other premium crops. The company’s patented technology harnesses liquid nitrogen to reduce biomass and then efficiently isolate, collect and preserve delicate resin glands (trichomes) containing prized compounds like cannabinoids and terpenes. Building on this technology, CryoMass has engineered its premier Trichome Separation unit (CryoSift Separator™), optimized via patented cryogenic processes to rapidly capture intact, high-value cannabis and hemp trichomes (CryoSift™). Much like sugar and flour refinements, the resulting CryoSift™ concentrate is a superior product compared to unprocessed biomass. For cultivators, reducing biomass into CryoSift™ slashes volume up to 80%, dramatically lowering storage, handling, and transportation costs. Properly stored, CryoSift™ prevents potency and terpene degradation, preserving value. For processors, the minimized input volume also enables considerable cost savings and logistics advantages. Extracting from CryoSift™ using solvents and manufacturing solventless products unlocks industrial scale yields unattainable otherwise. CryoMass anticipates its efficiencies will catalyze industry-wide shifts in cannabis and hemp post-harvest methods. Additionally, the technology shows promise for diverse trichome-rich plants.

Products and services

Cryomass has developed a patented technology for the capture of trichomes and terpenes from cannabis and hemp plants.

CRYM key facts

Ticker symbol

CRYM

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Denver, CO, United States

Country of incorporation

US

Year of incorporation

2011

Employees

9

Estimated market cap

$6.61M (as of Apr 16, 2025)

Shares outstanding

239,671,605

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Cryomass Technologies Inc. leadership

• Christian Noel — CEO
• Philip Blair Mullin — CFO, Treasurer
• Patricia Kovacevic — Corporate Secretary, General Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with C